$LGVN
Longeveron Inc. Stock $lgvn

$lgvn Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024042909 Filed on May 14, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$548.0K	$279.0K
YoY Change	96.42%	-24.59%
Cost Of Revenue	$219.0K	$203.0K
YoY Change	7.88%	190.0%
Gross Profit	$329.0K	$76.00K
YoY Change	332.89%	-74.67%
Gross Profit Margin	60.04%	27.24%
Selling, General & Admin	$2.200M	$2.012M
YoY Change	9.34%	-11.25%
% of Gross Profit	668.69%	2647.37%
Research & Development	$2.219M	$2.780M
YoY Change	-20.18%	94.81%
% of Gross Profit	674.47%	3657.89%
Depreciation & Amortization	$200.0K	$200.0K
YoY Change	0.0%	6.38%
% of Gross Profit	60.79%	263.16%
Operating Expenses	$4.419M	$4.792M
YoY Change	-7.78%	29.72%
Operating Profit	-$4.090M	-$4.716M
YoY Change	-13.27%	38.95%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$32.00K	$69.00K
YoY Change	-53.62%	-531.25%
Pretax Income	-$4.058M	-$4.647M
YoY Change	-12.67%	32.39%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.100M	-$4.647M
YoY Change	-11.77%	32.39%
Net Earnings / Revenue	-748.18%	-1665.59%
Basic Earnings Per Share	-$1.61	-$0.22
Diluted Earnings Per Share	-$1.61	-$0.22
COMMON SHARES
Basic Shares Outstanding	2.514M shares	21.03M shares
Diluted Shares Outstanding	2.514M shares	21.03M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.100M	$13.68M
YoY Change	-77.33%	-55.28%
Cash & Equivalents	$1.940M	$4.984M
Short-Term Investments	$1.160M	$8.693M
Other Short-Term Assets	$1.288M	$1.097M
YoY Change	17.41%	-7.82%
Inventory
Prepaid Expenses
Receivables	$178.0K	$96.00K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.757M	$14.87M
YoY Change	-74.73%	-53.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.348M	$2.810M
YoY Change	-16.44%	-40.35%
Goodwill
YoY Change
Intangibles	$2.263M	$2.425M
YoY Change	-6.68%
Long-Term Investments
YoY Change
Other Assets	$190.0K	$247.0K
YoY Change	-23.08%	5.56%
Total Long-Term Assets	$5.940M	$6.938M
YoY Change	-14.38%	-5.04%
TOTAL ASSETS
Total Short-Term Assets	$3.757M	$14.87M
Total Long-Term Assets	$5.940M	$6.938M
Total Assets	$9.697M	$21.81M
YoY Change	-55.53%	-44.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.467M	$457.0K
YoY Change	221.01%	-18.54%
Accrued Expenses	$2.401M	$613.0K
YoY Change	291.68%	-54.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.295M	$3.595M
YoY Change	47.29%	49.79%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$66.00K	$1.895M
YoY Change	-96.52%	-23.19%
Total Long-Term Liabilities	$1.361M	$1.895M
YoY Change	-28.18%	-23.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.295M	$3.595M
Total Long-Term Liabilities	$1.361M	$1.895M
Total Liabilities	$6.656M	$5.490M
YoY Change	21.24%	12.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$89.04M	-$67.42M
YoY Change	32.07%
Common Stock		$6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$100.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.041M	$16.32M
YoY Change
Total Liabilities & Shareholders Equity	$9.697M	$21.81M
YoY Change	-55.53%	-44.33%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$4.100M	-$4.647M
YoY Change	-11.77%	32.39%
Depreciation, Depletion And Amortization	$200.0K	$200.0K
YoY Change	0.0%	6.38%
Cash From Operating Activities	-$3.086M	-$5.848M
YoY Change	-47.23%	40.85%
INVESTING ACTIVITIES
Capital Expenditures	$16.00K	$42.00K
YoY Change	-61.9%	-135.59%
Acquisitions
YoY Change
Other Investing Activities	$61.00K	$461.0K
YoY Change	-86.77%	-47.91%
Cash From Investing Activities	$14.00K	$346.0K
YoY Change	-95.95%	-54.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$100.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$63.00K	-$17.00K
YoY Change	-470.59%	-87.94%
NET CHANGE
Cash From Operating Activities	-$3.086M	-$5.848M
Cash From Investing Activities	$14.00K	$346.0K
Cash From Financing Activities	$63.00K	-$17.00K
Net Change In Cash	-$3.009M	-$5.519M
YoY Change	-45.48%	56.52%
FREE CASH FLOW
Cash From Operating Activities	-$3.086M	-$5.848M
Capital Expenditures	$16.00K	$42.00K
Free Cash Flow	-$3.102M	-$5.890M
YoY Change	-47.33%	46.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.21
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2513587	shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40060
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 520
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	City Area Code CityAreaCode	(305)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	909-0840
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	LGVN
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1940000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4949000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	351000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	412000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1288000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	376000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	178000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	111000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	3757000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5848000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2348000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2529000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2263000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2287000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1139000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1221000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	190000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	193000	usd
CY2024Q1	us-gaap	Assets Assets	9697000	usd
CY2023Q4	us-gaap	Assets Assets	12078000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1467000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	638000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2401000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2152000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	601000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	593000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	826000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	506000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5295000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3889000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1295000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1448000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	66000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1361000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1448000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	6656000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5337000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92080000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	91823000	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	100000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89042000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84984000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3041000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6741000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9697000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12078000	usd
CY2024Q1	us-gaap	Revenues Revenues	548000	usd
CY2023Q1	us-gaap	Revenues Revenues	279000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	219000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	203000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	329000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	76000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2200000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2012000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2219000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2780000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	4419000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4792000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4090000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4716000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	32000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	69000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4058000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.21
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2513587	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2103362	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4058000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	58000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4057000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4589000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6741000	usd
CY2024Q1	lgvn	Stock Issued During Period Class A Common Stock Held For Taxes On Rs Us Vested StockIssuedDuringPeriodClassACommonStockHeldForTaxesOnRSUsVested	-21000	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-17000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	100000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	295000	usd
CY2024Q1	lgvn	Stock Issued During Period Unrealized Loss Attributable To Change In Market Value Of Available For Sale Securities StockIssuedDuringPeriodUnrealizedLossAttributableToChangeInMarketValueOfAvailableForSaleSecurities	1000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4058000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3041000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20503000	usd
CY2023Q1	lgvn	Stock Issued During Period Class A Common Stock Held For Taxes On Rs Us Vested StockIssuedDuringPeriodClassACommonStockHeldForTaxesOnRSUsVested	-17000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	421000	usd
CY2023Q1	lgvn	Stock Issued During Period Unrealized Loss Attributable To Change In Market Value Of Available For Sale Securities StockIssuedDuringPeriodUnrealizedLossAttributableToChangeInMarketValueOfAvailableForSaleSecurities	58000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16318000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4058000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	252000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	238000	usd
CY2023Q1	lgvn	Interest Earned On Marketable Securities InterestEarnedOnMarketableSecurities	72000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	295000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	421000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	67000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-122000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	912000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	694000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	829000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1294000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	320000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	50000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	249000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-38000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	63000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	76000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	66000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3086000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5848000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	61000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	461000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42000	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	31000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	73000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	346000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	37000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3009000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5519000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4949000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10503000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1940000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4984000	usd
CY2024Q1	lgvn	Dividend Attributable To Down Round Feature Of Warrants DividendAttributableToDownRoundFeatureOfWarrants	-97000	usd
CY2023Q1	lgvn	Dividend Attributable To Down Round Feature Of Warrants DividendAttributableToDownRoundFeatureOfWarrants	-68000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4100000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4600000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1900000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	400000	usd
CY2023Q1	lgvn	Expenditure Commitments Term ExpenditureCommitmentsTerm	P1Y
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of estimates:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The presentation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	100000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	178000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	111000	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	100000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2024Q1	us-gaap	Revenues Revenues	548000	usd
CY2023Q1	us-gaap	Revenues Revenues	279000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentrations of credit risk: </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments which potentially subject the Company to credit risk consist principally of cash and cash equivalents, marketable securities and accounts and grants receivable. Cash and cash equivalents are held in U.S. financial institutions. At times, the Company may maintain balances in excess of the federally insured amounts.</p>
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	1160000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	4376000	usd
CY2024Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	100000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6985000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6969000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	4637000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	4440000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2348000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2529000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3227000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	964000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2263000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3196000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	909000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2287000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	168000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	224000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	224000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	224000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	224000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	15000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1079000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	511000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	682000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	682000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	170000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2046000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	149000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1896000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	200000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	200000	usd
CY2024Q1	us-gaap	Conversion Of Stock New Issuance ConversionOfStockNewIssuance	200,000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	11239	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y
CY2024Q1	lgvn	Share Based Compensation Arrangement By Share Based Payment Stock Option Expiration Term ShareBasedCompensationArrangementByShareBasedPaymentStockOptionExpirationTerm	P10Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.05	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	43782	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.61
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	49.6
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	900000	usd
CY2024Q1	lgvn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P2Y
CY2023	lgvn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P2Y
CY2014Q4	us-gaap	Other Expenses OtherExpenses	265000	usd
CY2022Q4	lgvn	Sharebased Compensation Arrangement By Share Based Payment Award Options Rs Us Vested SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsRSUsVested	4814	shares
CY2022Q4	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	200000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	100000	usd
CY2024Q1	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	100000	usd
CY2014Q4	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	5000	usd
CY2014Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	50000	usd
CY2014Q4	lgvn	Terms Of Agreement TermsOfAgreement	P20Y
CY2024Q1	lgvn	Milestone Of Triggering Payments MilestoneOfTriggeringPayments	500000	usd
CY2023	lgvn	Milestone Fees Payable MilestoneFeesPayable	50000	usd
CY2016Q4	lgvn	Annual Net Sales Percentage AnnualNetSalesPercentage	0.01	pure
CY2016Q4	lgvn	Net Sales Of Sub Licensees NetSalesOfSubLicensees	0.10	pure
CY2016Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	250000	usd
CY2016Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	500000	usd
CY2016Q4	us-gaap	Professional Fees ProfessionalFees	27000	usd
CY2016Q4	lgvn	License Agreement Term licenseAgreementTerm	P20Y
CY2016Q4	lgvn	Incurred Terms IncurredTerms	P20Y
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	3000000	usd
CY2024Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	46000000	usd
CY2023Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	38000000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	824000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	210000	shares
CY2023Q4	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2029-04-13
CY2023Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	2.35
CY2024Q1	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	2.35
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	lgvn	Non Rule10b51 Arr Modified Flag NonRule10b51ArrModifiedFlag	false
CY2024Q1	lgvn	Rule10b51 Arr Modified Flag Rule10b51ArrModifiedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2103362	shares
CY2024Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2024Q1	lgvn	Class A Common Stock Issued For Rs Us Vested During Period ClassACommonStockIssuedForRSUsVestedDuringPeriod		usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts		usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023Q1	lgvn	Class A Common Stock Issued For Rs Us Vested During Period ClassACommonStockIssuedForRSUsVestedDuringPeriod		usd
CY2024Q1	lgvn	Interest Earned On Marketable Securities InterestEarnedOnMarketableSecurities		usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y219D
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001721484

Files In Submission

Name	View Source	Status
0001213900-24-042909-index-headers.html	Edgar Link	pending
0001213900-24-042909-index.html	Edgar Link	pending
0001213900-24-042909.txt	Edgar Link	pending
0001213900-24-042909-xbrl.zip	Edgar Link	pending
ea0205696-10q_longeveron.htm	Edgar Link	pending
ea020569601ex31-1_longeveron.htm	Edgar Link	pending
ea020569601ex31-2_longeveron.htm	Edgar Link	pending
ea020569601ex32-1_longeveron.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
lgvn-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
lgvn-20240331_cal.xml	Edgar Link	unprocessable
lgvn-20240331_def.xml	Edgar Link	unprocessable
lgvn-20240331_lab.xml	Edgar Link	unprocessable
lgvn-20240331_pre.xml	Edgar Link	unprocessable
ea0205696-10q_longeveron_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGVN
Longeveron Inc. Stock $lgvn

2024 Q1 Form 10-Q Financial Statement

#000121390024042909 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGVN Longeveron Inc. Stock $lgvn

2024 Q1 Form 10-Q Financial Statement

#000121390024042909 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGVN
Longeveron Inc. Stock $lgvn